Zhanhong Ren
Overview
Explore the profile of Zhanhong Ren including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
59
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhou X, Wang H, Yan B, Nie X, Chen Q, Yang X, et al.
Cardiovasc Drugs Ther
. 2024 Dec;
PMID: 39641901
Objective: Cardiovascular diseases (CVDs) are major public health problems that threaten the lives and health of individuals. The article has reviewed recent progresses about ferroptosis and ferroptosis-related intervention approaches for...
2.
Wang X, Nie X, Wang H, Ren Z
Mol Med Rep
. 2024 Sep;
30(5).
PMID: 39301654
Cardiac hypertrophy results from the heart reacting and adapting to various pathological stimuli and its persistent development is a major contributing factor to heart failure. However, the molecular mechanisms of...
3.
Hu M, Ren Z, Rong N, Bai M, Wu H, Yang M
AoB Plants
. 2024 Apr;
16(2):plae017.
PMID: 38585158
Evolution of cellular characteristics is a fundamental aspect of evolutionary biology, but knowledge about evolution at the cellular level is very limited. In particular, whether a certain intracellular characteristic evolved...
4.
Wang S, Wang X, Ling L, Li C, Ren Z
Mol Med Rep
. 2024 Mar;
29(5).
PMID: 38456539
Cardiac hypertrophy is one of the key processes in the development of heart failure. Notably, small GTPases and GTPase‑activating proteins (GAPs) serve essential roles in cardiac hypertrophy. RhoGAP interacting with...
5.
Zhou Z, Ou-Yang C, Chen Q, Ren Z, Guo X, Lei M, et al.
Front Immunol
. 2023 Dec;
14:1287130.
PMID: 38152400
Evidence from clinical research and animal studies indicates that inflammation is an important factor in the occurrence and development of cardiovascular disease (CVD). Emerging evidence shows that nucleic acids serve...
6.
Wang Q, Ni S, Ling L, Wang S, Xie H, Ren Z
Cardiovasc Ther
. 2023 Dec;
2023:8848808.
PMID: 38125702
Coronary artery disease (CAD) is the most prevalent cardiovascular disease worldwide, resulting in myocardial infarction (MI) and even sudden death. Following percutaneous coronary intervention (PCI), restenosis caused by vascular remodeling...
7.
Fang X, Wang S, Wang Q, Gong J, Li L, Lu H, et al.
Talanta
. 2023 Nov;
268(Pt 1):125339.
PMID: 37918241
Hydrogen sulfide (HS) is a multifunctional gaseous signaling molecule that plays a vital role in several biological processes. In the present study, a BODIPY-based fluorescent probe called 8-[4-((1,4,7,10-tetraazacyclododecane)methyl)phenyl]-4,4-difluoro-1,3,5,7-tetramethyl-4-bora-3a, 4a-diaza-s-indacene (BA-Cyclen)-Cu...
8.
Ren Z, Mao X, Wang S, Wang X
J Cell Mol Med
. 2023 Oct;
27(24):3974-3979.
PMID: 37830491
More and more attention is paid to diseases such as internal transfer and brain malformation which are caused by the abnormal morphogenesis of cilia. These cilia-related diseases are divided into...
9.
Lei M, Guo X, Yao Y, Shu T, Ren Z, Yang X, et al.
Exp Gerontol
. 2023 Oct;
182:112307.
PMID: 37804920
Cognitive impairment frequently coexists with diabetes. Trelagliptin is a once-weekly taking selective dipeptidyl peptidase-4 (DPP-4) inhibitor and a long-term effective hypoglycemic medicine; nonetheless, its effects for the treatment of diabetes-related...
10.
Ren Z, Zhang Z, Ling L, Liu X, Wang X
Front Pharmacol
. 2023 Sep;
14:1221881.
PMID: 37771726
Myocardial fibrosis, which is a common pathological manifestation of many cardiovascular diseases, is characterized by excessive proliferation, collagen deposition and abnormal distribution of extracellular matrix fibroblasts. In clinical practice, modern...